ea0063oc4.3 | Thyroid 1 | ECE2019
Bouzehouane Nadia
, Roy Pascal
, Decaussin-Petrucci Myriam
, Bertholon-Gregoire Mireille
, Bully Chantal
, Perrin Agnes
, Borson-Chazot Francoise
, Bournaud Claire
Background/objective: mETE has shown no effect on survival, and the 8th edition of the AJCC classification no longer considers mETE in the pT3 definition. Therefore, tumors with mETE below 40 mm are now staged pT1/pT2. However, controversy remains regarding mETE impact on disease recurrence. This study assessed the risk of recurrence of PTC patients previously classified as pT3 because of mETE, compared to PTC patients staged pT1-pT2.Methods: Monocentric...